Always Cold, Never Warm Enough: The Biology of Temperature Dysregulation in ME/CFS
There is a moment many people with ME/CFS know well: lying under two blankets in a room that isn’t cold, still unable to get warm. Or suddenly sweating without exertion. Or fingers turning white and numb in a mildly chilly room. Or discovering that a warm bath — something healthy people find restorative — leaves them exhausted for the rest of the day.
Temperature regulation should be automatic. For people with ME/CFS, it is unreliable, metabolically expensive, and often simply broken.
This article explains why — and connects temperature dysregulation to several other symptoms that seem unrelated but share the same upstream failures.
1 The thermostat in the brain
The body’s temperature regulation system is controlled primarily by the hypothalamus, a small but metabolically dense brain region that continuously monitors core body temperature and coordinates the response through the autonomic nervous system: dilating blood vessels to release heat when too warm, constricting them and triggering shivering to retain heat when too cold, directing sweat glands, adjusting blood distribution between core and periphery.
All of this is autonomic — it should happen automatically, below conscious awareness. In ME/CFS, three interconnected failures disrupt the entire system simultaneously.
2 Failure 1: The autonomic nervous system is dysregulated
The autonomic nervous system — the body’s involuntary control network for heart rate, blood pressure, blood flow, digestion, gland secretion, and temperature — is functionally impaired in most people with ME/CFS. This is not a peripheral finding. It is now one of the most consistently documented features of the disease.
The two branches of the autonomic system — sympathetic and parasympathetic — are normally in dynamic balance. In ME/CFS, this balance is disrupted. Several mechanisms contribute:
Autoantibodies against autonomic receptors. Research has documented elevated autoantibodies against the beta-adrenergic (β₁ and β₂) and muscarinic cholinergic (M3 and M4) receptors that autonomic nerve fibers use to communicate with target tissues, including blood vessels and sweat glands. These antibodies can act agonistically (inappropriately activating) or antagonistically (blocking) at these receptors, producing erratic autonomic signaling that cannot be corrected by the brain’s normal regulatory feedback.
Depleted central norepinephrine. Direct measurement of cerebrospinal fluid in the NIH’s deep phenotyping study of ME/CFS found reduced norepinephrine metabolites — direct chemical evidence that the central autonomic circuitry is running short of its primary signaling molecule. Norepinephrine drives the sympathetic responses that, among many other functions, constrict peripheral blood vessels to maintain core temperature in the cold.
Small fiber neuropathy. Skin punch biopsies confirm that 30–38% of ME/CFS patients have measurably reduced density of the small, unmyelinated nerve fibers that carry both pain and autonomic signals — including the autonomic fibers that control cutaneous blood flow and sweat gland activity. In patients with subclinical nerve involvement, the proportion is almost certainly higher. These are the exact fibers responsible for directing blood vessels to constrict or dilate in response to temperature.
The result: the peripheral vasculature receives imprecise, inconsistent, or blunted instructions from the brain. When the body needs to retain heat, the blood vessels may not constrict properly. When it needs to release heat, they may not dilate on cue. The thermostat sends commands; the actuators respond erratically.
3 Failure 2: Producing heat is expensive, and there isn’t enough energy
Thermoregulation is not passive. Generating heat — whether through shivering, through non-shivering thermogenesis in brown adipose tissue, or simply through maintaining normal metabolic activity in cells — requires ATP, the body’s universal energy currency.
In ME/CFS, ATP production is impaired at the mitochondrial level. The electron transport chain — the machinery that generates the vast majority of cellular ATP — leaks electrons at several times the normal rate, producing reactive oxygen species instead of useful energy and degrading the mitochondrial structures themselves. The result is a reduced ATP output per unit of metabolic substrate consumed.
For thermoregulation, this creates a direct problem: heat generation costs energy the body doesn’t have to spare.
Shivering — one of the primary cold-defense mechanisms — is involuntary rapid muscle contraction. Muscle contraction consumes ATP. In a body where ATP production is already running below capacity, the sustained ATP demand of shivering may not be sustainable. The muscles may shiver briefly, then fail to sustain the response. The person remains cold.
Non-shivering thermogenesis, which involves brown adipose tissue burning fat to generate heat directly, also depends on mitochondrial activity. In the context of widespread mitochondrial dysfunction, this pathway is likely impaired as well.
The cold that people with ME/CFS feel is not, in many cases, a perception problem. It is the physical consequence of a thermoregulatory system that lacks the fuel to run properly.
4 Failure 3: Blood doesn’t go where it needs to go
Core body temperature is maintained partly by keeping warm, oxygenated blood close to vital organs. This requires the cardiovascular system to distribute blood appropriately — and in ME/CFS, that distribution is disrupted.
Most people with ME/CFS have documented reductions in total blood volume — plasma volume is typically 10–20% below normal. With less total blood, the body increasingly prioritizes core organ perfusion, leaving less arterial flow available to the extremities.
Compounding this, orthostatic intolerance — the failure to maintain adequate blood flow when upright — is present in the majority of ME/CFS patients. When standing, blood pools in the lower body’s venous circulation. The autonomic system should constrict those vessels and increase cardiac output (preload — the volume filling the heart before each beat) to compensate; in ME/CFS, this response is impaired. Cardiac output falls. The brain and the extremities both receive less arterial blood.
The extremities receive less warm blood. They cool faster. And because the vasoconstriction that would normally limit heat loss from the hands and feet is dysregulated, the body cannot efficiently direct what warmth it has.
Raynaud’s phenomenon — in which fingers and toes turn white, then blue, then red in response to cold or stress — appears in a significant subset of ME/CFS patients. It reflects the opposite problem to the inadequate vasoconstriction described above: an exaggerated sympathetic vasoconstrictive response that cuts off blood flow to the digits entirely. The white phase is maximal arterial constriction; the blue phase is ischemia from absent flow; the red phase is a flooding rebound when the constriction releases. Both the failure to constrict adequately (chronic cold extremities) and the excessive constriction of Raynaud’s episodes are expressions of the same dysregulated autonomic system — one that cannot maintain proportionate, calibrated responses to thermal and circulatory signals.
5 Why heat is also a problem
ME/CFS patients who feel cold much of the time often also experience heat intolerance — difficulty tolerating warm environments, feeling immediately unwell in the sun, or crashing after a warm bath or shower.
This seems contradictory. It isn’t.
The same impaired thermoregulation that prevents adequate cold defense also prevents adequate heat defense. Heat dissipation requires blood vessels in the skin to dilate, sweating to activate, and cardiac output to increase to bring warm blood to the skin surface for cooling. All of these require robust autonomic signaling and adequate cardiovascular reserve. In ME/CFS, none of these are reliable.
Additionally, warm environments cause vasodilation — blood pools toward the periphery, reducing venous return to the heart and reducing cardiac output. In a healthy cardiovascular system, this is compensated by increased heart rate and vasoconstriction elsewhere. In ME/CFS, where preload failure (insufficient blood filling the heart) is already present, this vasodilation further reduces stroke volume and cardiac output. The brain becomes hypoperfused. Orthostatic symptoms worsen. The person feels faint, nauseated, and cognitively impaired — not because they’re overheating, but because the cardiovascular system cannot maintain adequate perfusion under thermal stress.
A warm bath or shower causes the same vasodilation. The physical warmth is real. The crash afterward is cardiovascular and autonomic, not thermal.
6 The night sweats
Night sweats in ME/CFS are common and often severe — waking up drenched despite a cool room, or sweating through clothing at rest.
In healthy people, sweating is thermoregulatory: the body activates sweat glands to cool down. In ME/CFS, sweating can occur as a dysautonomic event: the autonomic system fires the wrong signal at the wrong time, activating sweat glands not because the body is too hot but because the autonomic circuitry is misfiring. Cytokines from chronic immune activation can also directly trigger sweating — the same mechanism responsible for the “night sweats” associated with active infections.
The person is not too warm. They may be cold again minutes later. The sweat is a thermoregulatory output from a system that has lost accurate sensory input.
7 Other surprising symptoms with the same roots
Temperature dysregulation is one manifestation of a set of failures — autonomic dysfunction, energy deficits, reduced blood volume, cerebral hypoperfusion — that produce a range of symptoms that seem unrelated until you understand the underlying biology.
Breathing difficulty with normal oxygen levels. Many people with ME/CFS experience shortness of breath or the sensation of not getting a satisfying breath, even when pulse oximetry shows normal oxygen saturation. The problem is not oxygen intake — it is oxygen delivery and utilization at the cellular level. Autonomic dysfunction alters respiratory drive. Preload failure reduces cardiac output, meaning less blood is delivered to tissues per breath. Respiratory muscles can fatigue rapidly in energy-deficient states. A 2025 study found that approximately 70% of ME/CFS patients show abnormal breathing patterns with desynchronization between chest and abdominal movement — using accessory breathing muscles instead of the diaphragm, which consumes roughly three times as much energy per breath.
Blurred vision that varies by day. Vision quality in ME/CFS can fluctuate dramatically with energy state. The ciliary muscle that adjusts lens focus requires sustained ATP to function. The autonomic fibers controlling pupil diameter are part of the same dysregulated system. On a low-energy day, the ciliary muscle fatigues, focus becomes effortful or impossible, and diplopia (double vision) may occur. On a better-energy day, vision improves. This is not a vision problem in the ophthalmological sense — it is an energy and autonomic problem with visual consequences.
Cognitive symptoms that worsen when standing. Brain fog in ME/CFS is not a fixed state — it reliably worsens with standing and upright posture, and often improves when lying down. This tracks directly with cerebral perfusion: when upright, cardiac output falls and blood pools below the heart. The brain receives less blood. Cognitive function — which is among the most energy- and perfusion-dependent processes in the body — deteriorates rapidly. Tilt-table studies from one Dutch referral center found that 91% of ME/CFS patients showed measurably reduced cardiac output and cerebral blood flow during orthostatic stress, with cognitive symptoms correlating directly to the degree of blood flow reduction — findings that await independent replication but are consistent with the clinical picture. The brain fog is not metaphorical. It is hypoperfusion.
Sound and light sensitivity. Hyperacusis (sensitivity to sound) and photophobia (sensitivity to light) are present in 60–90% of people with ME/CFS, often at levels that require darkened rooms or earplugs in normal environments. Normal conversation volume can be painfully loud. Sunlight through a window can be intolerable. The mechanisms overlap with those described in previous articles: central sensitization has lowered the thresholds of sensory-processing neurons throughout the nervous system, and the metabolically demanding cells of the retina and cochlea are particularly vulnerable to the energy deficits that impair their function. The sensory nervous system, like the motor and autonomic nervous systems, is running in a sensitized, energy-depleted state.
“Subjective hypoglycemia” with normal blood glucose. Many ME/CFS patients experience episodes of feeling as though their blood sugar has crashed — shakiness, weakness, cognitive dimming, intense hunger — even when blood glucose is normal. The mechanism is orthostatic intolerance, not metabolic: the falling cardiac output and cerebral hypoperfusion that accompany standing mimic the subjective experience of hypoglycemia. Patients may have spent years trying to manage these episodes by eating frequently, when the actual intervention needed is cardiovascular — increased fluid, sodium, and potentially compression garments to support venous return.
8 What all of these have in common
Cold intolerance, heat intolerance, night sweats, Raynaud’s, breathlessness, fluctuating vision, cognitive symptoms that track with posture, sensory hypersensitivity: these are not a random collection of unrelated complaints. They are a coherent pattern.
Autonomic dysfunction — imprecise, unreliable communication between the brain and the body’s involuntary systems — explains the cardiovascular and thermoregulatory failures. Mitochondrial energy deficits explain why repair and compensation are impossible. Reduced blood volume explains why even small cardiovascular stresses produce outsized consequences. Cerebral hypoperfusion explains why cognition, vision, and sensory gating all worsen in posture-dependent, energy-dependent ways. Central sensitization explains why sensory inputs that would be filtered as unimportant in a healthy nervous system are experienced as overwhelming.
The person lying under two blankets, still cold, exhausted from the effort of warming up, is not exaggerating their discomfort. Their thermoregulatory system has lost reliable control of the processes that generate and retain heat — the fuel is insufficient, the signaling is imprecise, the blood that carries warmth to the extremities is reduced in volume and unpredictably distributed.
That is not weakness. That is physiology.
9 A note on the research
The mechanisms described here draw on autonomic testing studies, cardiovascular imaging (including near-infrared spectroscopy and tilt-table protocols), skin biopsy research, cerebrospinal fluid analysis from the NIH’s deep phenotyping study of ME/CFS, and the literature on autoantibodies against autonomic receptors. Temperature dysregulation and autonomic dysfunction are among the most consistently documented features of ME/CFS across cohorts. Where findings are specific to single groups or not yet independently replicated, this is noted in the underlying documentation.